Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Eur J Haematol

Retrieve available abstracts of 72 articles:
HTML format
Text format



Single Articles


    April 2017
  1. KOZLOWSKI P, Lennmyr E, Ahlberg L, Bernell P, et al
    Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden.
    Eur J Haematol. 2017 Apr 18. doi: 10.1111/ejh.12896.
    PubMed     Text format     Abstract available


    March 2017
  2. ZADA M, Lerner D, Piltz Y, Perry C, et al
    Familial Chronic Lymphocytic Leukemia in Israel: A Disproportionate Distribution Among Ashkenazi Jews.
    Eur J Haematol. 2017 Mar 31. doi: 10.1111/ejh.12889.
    PubMed     Text format     Abstract available


  3. TAGHILOO S, Allahmoradi E, Tehrani M, Hossein-Nataj H, et al
    Frequency and functional characterization of Exhausted CD8+ T-cells in chronic lymphocytic leukemia.
    Eur J Haematol. 2017 Mar 17. doi: 10.1111/ejh.12880.
    PubMed     Text format     Abstract available


  4. NOLTE F, Mossner M, Jann JC, Nowak D, et al
    Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects.
    Eur J Haematol. 2017;98:302-310.
    PubMed     Text format     Abstract available


  5. AL-SAWAF O, Fischer K, Herling CD, Ritgen M, et al
    Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.
    Eur J Haematol. 2017;98:254-262.
    PubMed     Text format     Abstract available


    February 2017
  6. LAZAREVIC V, Rosso A, Juliusson G, Antunovic P, et al
    Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: a population-based study from the Swedish AML Registry.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12861.
    PubMed     Text format     Abstract available


  7. SEKINE M, Kubuki Y, Kameda T, Takeuchi M, et al
    Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12863.
    PubMed     Text format     Abstract available


  8. THOTA S, Advani A
    Inotuzumab ozogamicin in relapsed b-cell acute lymphoblastic leukemia.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12862.
    PubMed     Text format     Abstract available


  9. GONZALEZ-GASCON Y MARIN I, Martin AA, Hernandez-Sanchez M, Robledo C, et al
    Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.
    Eur J Haematol. 2017;98:142-148.
    PubMed     Text format     Abstract available


    January 2017
  10. MORI N, Ohwashi-Miyazaki M, Yoshinaga K, Okada M, et al
    Tumor suppressor gene methylation on the short arm of chromosome 1 in chronic myelogenous leukemia.
    Eur J Haematol. 2017 Jan 27. doi: 10.1111/ejh.12857.
    PubMed     Text format     Abstract available


  11. CAHU X, Carre M, Recher C, Pigneux A, et al
    Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.
    Eur J Haematol. 2017 Jan 25. doi: 10.1111/ejh.12850.
    PubMed     Text format     Abstract available


  12. SODERLUND S, Dahlen T, Sandin F, Olsson-Stromberg U, et al
    Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.
    Eur J Haematol. 2017;98:57-66.
    PubMed     Text format     Abstract available


    December 2016
  13. FATHI AT, Chen YB
    The Role of FLT3 Inhibitors in the Treatment of FLT3 Mutated Acute Myeloid Leukemia.
    Eur J Haematol. 2016 Dec 21. doi: 10.1111/ejh.12841.
    PubMed     Text format     Abstract available


  14. ALGRIN C, Golmard JL, Michallet M, Reman O, et al
    Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia.
    Eur J Haematol. 2016 Dec 10. doi: 10.1111/ejh.12836.
    PubMed     Text format     Abstract available


    October 2016
  15. KRON F, Kutsch N, Kostenko A, Dohle I, et al
    Economic evaluation of Chronic Lymphatic Leukemia from a Hospital Management Perspective.
    Eur J Haematol. 2016 Oct 11. doi: 10.1111/ejh.12817.
    PubMed     Text format     Abstract available


  16. HEMMATI PG, Vuong LG, Terwey TH, Jehn CF, et al
    Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
    Eur J Haematol. 2016 Oct 5. doi: 10.1111/ejh.12815.
    PubMed     Text format     Abstract available


    September 2016
  17. HEIBLIG M, Elhamri M, Jeune CL, Laude MC, et al
    Acute myeloid leukemia in the elderly (age 70 years or older): Long-term survivors.
    Eur J Haematol. 2016 Sep 26. doi: 10.1111/ejh.12811.
    PubMed     Text format     Abstract available


  18. SILLA L, Dulley F, Saboya R, Kerbauy F, et al
    Brazilian guidelines on HSCT in acute myeloid leukemia.
    Eur J Haematol. 2016 Sep 13. doi: 10.1111/ejh.12808.
    PubMed     Text format     Abstract available


  19. DEGWERT N, Latuske E, Vohwinkel G, Stamm H, et al
    Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Eur J Haematol. 2016;97:239-44.
    PubMed     Text format     Abstract available


    August 2016
  20. ROMBOUT A, Verhasselt B, Philippe J
    Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.
    Eur J Haematol. 2016 Aug 9. doi: 10.1111/ejh.12789.
    PubMed     Text format     Abstract available


  21. HEHLMANN R
    CML - we are not there yet.
    Eur J Haematol. 2016;97:107.
    PubMed     Text format    


  22. KRISTENSEN L, Kristensen T, Abildgaard N, Royo C, et al
    LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
    Eur J Haematol. 2016;97:175-82.
    PubMed     Text format     Abstract available


  23. THIELEN N, Visser O, Ossenkoppele G, Janssen J, et al
    Chronic myeloid leukemia in the Netherlands: a population-based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012.
    Eur J Haematol. 2016;97:145-54.
    PubMed     Text format     Abstract available


    July 2016
  24. ANSARI J, Naqash AR, Munker R, El-Osta H, et al
    Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.
    Eur J Haematol. 2016;97:9-16.
    PubMed     Text format     Abstract available


    May 2016
  25. MALMBERG EB, Stahlman S, Rehammar A, Samuelsson T, et al
    Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next generation sequencing.
    Eur J Haematol. 2016 May 20. doi: 10.1111/ejh.12780.
    PubMed     Text format     Abstract available


  26. GEISSLER K, Jager E, Barna A, Sliwa T, et al
    In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia.
    Eur J Haematol. 2016 May 9. doi: 10.1111/ejh.12773.
    PubMed     Text format     Abstract available


  27. WOLF D, Mayer K
    When and how to 'FLAMSA-RIC' in acute myeloid leukemia?
    Eur J Haematol. 2016;96:445-6.
    PubMed     Text format    


  28. HOLTICK U, Shimabukuro-Vornhagen A, Chakupurakal G, Theurich S, et al
    FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.
    Eur J Haematol. 2016;96:475-82.
    PubMed     Text format     Abstract available


    April 2016
  29. SCHMOHL JU, Nuebling T, Wild J, Kroell T, et al
    RANK-L expression on blasts in patients with acute myeloid leukemia is associated with survival, PD-1/PD-1L expression has no impact.
    Eur J Haematol. 2016 Apr 20. doi: 10.1111/ejh.12762.
    PubMed     Text format     Abstract available


    March 2016
  30. SAINI L, Brandwein J, Turner R, Larratt L, et al
    The FLAG Chemotherapy Regimen Is an Alternative to Anthracycline Based Therapy for the Treatment of Acute Myeloid Leukemia for Patients with Pre-Existing Cardiac Disease.
    Eur J Haematol. 2016 Mar 29. doi: 10.1111/ejh.12757.
    PubMed     Text format     Abstract available


  31. SARANG Z, Gyurina K, Scholtz B, Kiss C, et al
    Altered expression of autophagy-related genes might contribute to glucocorticoid resistance in precursor B-cell type acute lymphoblastic leukemia.
    Eur J Haematol. 2016 Mar 7. doi: 10.1111/ejh.12753.
    PubMed     Text format     Abstract available


    February 2016
  32. BARON F, Nagler A
    Best allogeneic transplantation approach for AML patients in first CR: is delayed unrelated donor bone marrow transplantation better than immediate unrelated cord blood transplantation?
    Eur J Haematol. 2016 Feb 10. doi: 10.1111/ejh.12745.
    PubMed     Text format     Abstract available


  33. GUNNARSSON N, Sandin F, Hoglund M, Stenke L, et al
    Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
    Eur J Haematol. 2016 Feb 2. doi: 10.1111/ejh.12743.
    PubMed     Text format     Abstract available


  34. DAHLEN T, Kalin M, Cederlund K, Nordlander A, et al
    Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
    Eur J Haematol. 2016;96:175-80.
    PubMed     Text format     Abstract available


    January 2016
  35. LIM SJ, Lim MJ, Raptis A, Hou JZ, et al
    Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant.
    Eur J Haematol. 2016;96:55-9.
    PubMed     Text format     Abstract available


  36. GENTILE M, Cutrona G, Molica S, Ilariucci F, et al
    Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
    Eur J Haematol. 2016;96:36-45.
    PubMed     Text format     Abstract available


    December 2015
  37. YANADA M, Kanda J, Ohtake S, Fukuda T, et al
    Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission.
    Eur J Haematol. 2015 Dec 18. doi: 10.1111/ejh.12723.
    PubMed     Text format     Abstract available


  38. BASSAN R, Maino E, Cortelazzo S
    Lymphoblastic lymphoma: an updated review on biology, diagnosis and treatment.
    Eur J Haematol. 2015 Dec 17. doi: 10.1111/ejh.12722.
    PubMed     Text format     Abstract available


  39. MAURER C, Pflug N, Bahlo J, Kluth S, et al
    Bendamustine and Rituximab in Combination with Lenalidomide in Patients with Chronic Lymphocytic Leukemia.
    Eur J Haematol. 2015 Dec 8. doi: 10.1111/ejh.12714.
    PubMed     Text format     Abstract available


  40. TAMARA S, Irina S, Alexey B, Nataliya P, et al
    The Ability of Multipotent Mesenchymal Stromal Cells from the Bone Marrow of Patients with Leukemia to Maintain Normal Hematopoietic Progenitor Cells.
    Eur J Haematol. 2015 Dec 8. doi: 10.1111/ejh.12713.
    PubMed     Text format     Abstract available


    November 2015
  41. ALVAREZ-ZAVALA M, Riveros-Magana AR, Garcia-Castro B, Barrera-Chairez E, et al
    WNT receptors profile expression in mature blood cells and immature leukemic cells; RYK emerges as a hallmark receptor of acute leukemia.
    Eur J Haematol. 2015 Nov 11. doi: 10.1111/ejh.12698.
    PubMed     Text format     Abstract available


    October 2015
  42. HAUGE M, Bruserud O, Hatfield KJ
    Targeting of cell metabolism in human acute myeloid leukemia - more than targeting of IDH mutations and PI3K-AKT-mTOR signaling?
    Eur J Haematol. 2015 Oct 14. doi: 10.1111/ejh.12690.
    PubMed     Text format     Abstract available


    September 2015
  43. JARFELT M, Andersen NH, Glosli H, Jahnukainen K, et al
    Cardiac function in Survivors of Childhood Acute Myeloid Leukemia Treated with Chemotherapy Only: A NOPHO-AML Study.
    Eur J Haematol. 2015 Sep 18. doi: 10.1111/ejh.12683.
    PubMed     Text format     Abstract available


  44. XICOY B, Germing U, Jimenez MJ, Garcia O, et al
    Response to erythropoietic stimulating agents in patients with chronic myelomonocytic leukemia.
    Eur J Haematol. 2015 Sep 5. doi: 10.1111/ejh.12679.
    PubMed     Text format     Abstract available


  45. CRAMER P, Langerbeins P, Eichhorst B, Hallek M, et al
    Advances in first-line treatment of chronic lymphocytic leukemia current recommendations on management and first-line treatment by the german cll study group (gcllsg).
    Eur J Haematol. 2015 Sep 2. doi: 10.1111/ejh.12678.
    PubMed     Text format     Abstract available


    August 2015
  46. CRYSANDT M, Kramer M, Ehninger G, Bornhauser M, et al
    A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia.
    Eur J Haematol. 2015 Aug 16. doi: 10.1111/ejh.12675.
    PubMed     Text format     Abstract available


  47. FREITAS T, Marktel S, Piemontese S, Carrabba MG, et al
    High rate of hematological responses to sorafenib in FLT3-ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation.
    Eur J Haematol. 2015 Aug 11. doi: 10.1111/ejh.12647.
    PubMed     Text format     Abstract available


  48. VINOD SHAH M, Litzow MR
    Emerging role of CEBP-alpha mutations in acute myeloid leukemia.
    Eur J Haematol. 2015;95:99-100.
    PubMed     Text format    


    July 2015
  49. BRAEKELEER M
    BCR-ABL1 b3a2 AND b2a2 TRANSCRIPTS IN CHRONIC MYELOID LEUKEMIA: DOES IT MATTER?
    Eur J Haematol. 2015 Jul 24. doi: 10.1111/ejh.12639.
    PubMed     Text format     Abstract available


  50. DAVIDE L, Anna C, Gianpaolo N, Laura P, et al
    Multicenter survey to explore current survival of patients with acute myeloid leukemia who failed induction chemotherapy.
    Eur J Haematol. 2015 Jul 17. doi: 10.1111/ejh.12635.
    PubMed     Text format     Abstract available


  51. OSTENDORF BN, Terwey TH, Hemmati PG, Bohmer D, et al
    Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation.
    Eur J Haematol. 2015;95:90-2.
    PubMed     Text format     Abstract available


    June 2015
  52. NOVARETTI MC
    Rethinking the gold standard for recurrent DNA mutations detection in Acute Myeloid Leukemia.
    Eur J Haematol. 2015 Jun 25. doi: 10.1111/ejh.12604.
    PubMed     Text format     Abstract available


  53. BENE MC, Grimwade D, Haferlach C, Haferlach T, et al
    Leukemia diagnosis: today and tomorrow.
    Eur J Haematol. 2015 Jun 25. doi: 10.1111/ejh.12603.
    PubMed     Text format     Abstract available


  54. LAUFER CB, Roberts O
    Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine.
    Eur J Haematol. 2015 Jun 24. doi: 10.1111/ejh.12598.
    PubMed     Text format     Abstract available


  55. ALDOSS I, Douer D, Behrendt CE, Chaudhary P, et al
    Toxicity profile of repeated doses of PEG-Asparaginase incorporated into a pediatric-type regimen for Adult Acute Lymphoblastic Leukemia.
    Eur J Haematol. 2015 Jun 10. doi: 10.1111/ejh.12600.
    PubMed     Text format     Abstract available


  56. LIN HX, Sjaarda J, Dyck J, Stringer R, et al
    Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia.
    Eur J Haematol. 2015 Jun 8. doi: 10.1111/ejh.12597.
    PubMed     Text format     Abstract available


  57. PULTE D, Redaniel MT, Bird J, Jeffreys M, et al
    Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century.
    Eur J Haematol. 2015;94:540-5.
    PubMed     Text format     Abstract available


    May 2015
  58. VOSO MT, Niscola P, Piciocchi A, Fianchi L, et al
    Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low-blast count acute myeloid leukemia.
    Eur J Haematol. 2015 May 28. doi: 10.1111/ejh.12595.
    PubMed     Text format     Abstract available


  59. GARG S, Shanmukhaiah C, Marathe S, Mishra P, et al
    Differential antigen expression and aberrant signalling via PI3/AKT, MAP/ERK, JAK/STAT and Wnt/beta catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia (AML).
    Eur J Haematol. 2015 May 23. doi: 10.1111/ejh.12592.
    PubMed     Text format     Abstract available


  60. MO XD, Zhang XH, Xu LP, Wang Y, et al
    Salvage chemotherapy followed by granulocyte colony-stimulating factor-primed donor leukocyte infusion with graft-versus-host disease control for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem c
    Eur J Haematol. 2015 May 23. doi: 10.1111/ejh.12591.
    PubMed     Text format     Abstract available


  61. SALEK C, Folber F, Fronkova E, Prochazka B, et al
    Early mrd response as a prognostic factor in adult patients with acute lymphoblastic leukemia.
    Eur J Haematol. 2015 May 21. doi: 10.1111/ejh.12587.
    PubMed     Text format     Abstract available


  62. LAZAREVIC V, Horstedt AS, Johansson B, Antunovic P, et al
    Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.
    Eur J Haematol. 2015;94:419-23.
    PubMed     Text format     Abstract available


  63. SCOPIM-RIBEIRO R, Machado-Neto JA, Campos Pde M, Silva CA, et al
    Ten-eleven-translocation 2 (TET2) is downregulated in myelodysplastic syndromes.
    Eur J Haematol. 2015;94:413-8.
    PubMed     Text format     Abstract available


    April 2015
  64. FALK IJ, Willander K, Chaireti R, Lund J, et al
    TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome.
    Eur J Haematol. 2015;94:355-62.
    PubMed     Text format     Abstract available


    March 2015
  65. WOLF D
    Another piece of the puzzle--optimal TKI selection before treatment discontinuation in CML.
    Eur J Haematol. 2015;94:189-90.
    PubMed     Text format    


  66. SEDA V, Mraz M
    B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
    Eur J Haematol. 2015;94:193-205.
    PubMed     Text format     Abstract available


  67. NASEEM S, Rastogi P, Nahar Saikia U, Varma N, et al
    What lies inside the cup?
    Eur J Haematol. 2015;94:281-2.
    PubMed     Text format    


    February 2015
  68. LE JEUNE C, Thomas X
    Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia.
    Eur J Haematol. 2015;94:99-108.
    PubMed     Text format     Abstract available


    January 2015
  69. AUSTIN G, Holcroft A, Rinne N, Wang L, et al
    Evidence that the pregnane X and retinoid receptors PXR, RAR and RXR may regulate transcription of the transporter hOCT1 in chronic myeloid leukaemia cells.
    Eur J Haematol. 2015;94:74-8.
    PubMed     Text format     Abstract available


  70. HUBEL K, de la Rubia J, Azar N, Corradini P, et al
    Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective.
    Eur J Haematol. 2015;94:12-22.
    PubMed     Text format     Abstract available


    October 2014
  71. FAN H, Ortega V, Fanasch HM, Wang Y, et al
    PML-RARA fusion resulting from a cryptic insertion of RARA gene into PML gene without the reciprocal RARA-PML fusion: clinical, cytogenetic, and molecular characterization and prognosis.
    Eur J Haematol. 2014;93:354-8.
    PubMed     Text format     Abstract available


    March 2014
  72. AHLMANN M, Meyer C, Marschalek R, Burkhardt B, et al
    Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.
    Eur J Haematol. 2014 Mar 17. doi: 10.1111/ejh.12314.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: